Skip to content
Recall Observatory FDA recall evidence

Device product

Medtronic SynchroMed II, Model 8637, (The SynchroMed¿ II Pump is supplied in 20 ml or 40 ml reservoir size.) Sterilized using ethylene oxide. The pump is part of an infusion system that stores and delivers a prescribed drug to a specific site. The implantable components of the SynchroMed II Infusion System include the pump, catheter, and catheter accessories.

Z-0497-2013

November 09, 2012

Class I

Product summary

Firm
Medtronic Neuromodulation
Event
Event 63712
Status
Terminated
Classification
Class I
Quantity
174,700 devices total
Official record key
device-enforcement:Z-0497-2013

Official wording

Reason: Medtronic notified Healthcare Professionals of the impact of unapproved drugs on the performance of the SynchroMed infusion pump system. Use of unapproved drugs with SynchroMed pumps can result in an increased risk of permanent motor stall and cessation of drug infusion. UPDATE 2/1/2016: Medtronic received approval to incorporate enhancements to the SynchroMed II pump which decreases the potential for internal electrical shorting and motor corrosion, and is retrieving any unused pumps.

Code information: All SynchroMed EL and SynchroMed II pumps

Distribution pattern: Worldwide distribution: USA (nationwide) and countries including: Canada and Mexico.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Medtronic notified Healthcare Professionals of the impact of unapproved drugs on the performance of the SynchroMed infusion pump system. Use of unapproved drugs with SynchroMed pumps can result in an increased risk of permanent motor stall and cessation of drug infusion. UPDATE 2/1/2016: Medtronic received approval to incorporate enhancements to the SynchroMed II pump which decreases the potential for internal electrical shorting and motor corrosion, and is retrieving any unused pumps.